Dietetics professor explains who should and should not embrace the latest weight-loss drugs
Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...
Healio5h
Novel drug confers weight loss of about 20% at 1 year in phase 2 study
Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...
Rolling Out21h
A new breakthrough could change how we manage weight loss
PGC-1α research offers new hope for weight loss by boosting metabolic efficiency and providing accessible management ...
Hosted on MSN21h
Ozempic, Wegovy, and Mounjaro: Your Go-To Guide for Weight Loss with Meds
Everything you need to know about using Ozempic, Wegovy, and Mounjaro to shed those extra pounds. We dive into their perks, ...
Health and Me on MSN23h
A New Ozempic? Researchers Develop New Weight Loss Drug That Doesn't Cause Nausea
The drug's development was funded by Novo Nordisk, the maker of popular semaglutide drugs like Ozempic and Wegovy. While these GLP-1 receptor agonists are effective in weight management, they often ...